Employees: 11 (2023.0)Legal category: 5585Size: PMECreation date: 2007-04-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CAYENNE (97300), Guyane
PHARMACIE DE CAYENNE : revenue, balance sheet and financial ratios
PHARMACIE DE CAYENNE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CAYENNE (97300),
this company of category PME
shows in 2023 a revenue of 5.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE CAYENNE (SIREN 495312522)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
5 213 629 €
5 595 776 €
5 556 388 €
5 500 614 €
5 970 687 €
6 300 857 €
6 023 984 €
N/C
Net income
143 082 €
85 747 €
36 829 €
102 898 €
94 694 €
178 189 €
275 505 €
225 879 €
342 080 €
EBITDA
N/C
187 568 €
191 130 €
193 347 €
157 780 €
325 081 €
438 839 €
384 511 €
N/C
Net margin
N/C
1.6%
0.7%
1.9%
1.7%
3.0%
4.4%
3.7%
N/C
Revenue and income statement
In 2024, PHARMACIE DE CAYENNE generates positive net income of 143 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 342 k€ -> 143 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
143 082 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
13.547%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.064%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE CAYENNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
48.638
39.751
28.314
23.41
26.781
27.075
24.629
15.671
13.547
Financial autonomy
58.719
60.887
67.823
72.003
68.771
68.571
71.16
76.239
77.064
Repayment capacity
None
3.575
2.192
2.605
6.219
4.569
6.827
2.038
None
Cash flow / Revenue
None%
4.7%
5.579%
4.214%
2.128%
2.901%
1.714%
4.035%
None%
Sector positioning
Debt ratio
13.552024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE DE CAYENNE (13.55) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
77.06%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+5 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE CAYENNE (77.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
2.04 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good-40 pts over 2 years
In 2023, the repayment capacity of PHARMACIE DE CAYENNE (2.04) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 224.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
224.38
Liquidity indicators evolution PHARMACIE DE CAYENNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
239.348
206.083
223.334
256.544
242.51
252.836
261.368
237.125
224.38
Interest coverage
None
6.06
2.939
0.874
0.0
0.0
0.0
0.0
None
Sector positioning
Liquidity ratio
224.382024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-7 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE CAYENNE (224.38) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.0x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE CAYENNE (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE CAYENNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
1 004 740 €
889 177 €
917 217 €
907 161 €
812 011 €
901 871 €
642 997 €
0 €
Inventory turnover (days)
0
33
33
34
36
34
35
34
0
Customer payment term (days)
0
13
10
9
11
11
10
12
0
Supplier payment term (days)
0
39
29
26
29
27
22
27
0
Positioning of PHARMACIE DE CAYENNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE CAYENNE is estimated at
1 997 530 €
(range 1 391 048€ - 2 988 419€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1391k€1997k€2988k€
1 997 530 €Range: 1 391 048€ - 2 988 419€
NAF 5 année 2024
Valuation method used
Net Income Multiple
143 082 €
×
14.0x
=1 997 531 €
Range: 1 391 049€ - 2 988 420€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE CAYENNE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE CAYENNE
What is the revenue of PHARMACIE DE CAYENNE ?
The revenue of PHARMACIE DE CAYENNE in 2023 is 5.2 M€.
Is PHARMACIE DE CAYENNE profitable?
Yes, PHARMACIE DE CAYENNE generated a net profit of 143 k€ in 2024.
Where is the headquarters of PHARMACIE DE CAYENNE ?
The headquarters of PHARMACIE DE CAYENNE is located in CAYENNE (97300), in the department Guyane.
Where to find the tax return of PHARMACIE DE CAYENNE ?
The tax return of PHARMACIE DE CAYENNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE CAYENNE operate?
PHARMACIE DE CAYENNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart